Literature DB >> 12444813

Excessive antipsychotic dosing in 2 U.S. State hospitals.

Francisco J Diaz1, Jose De Leon.   

Abstract

BACKGROUND: This retrospective study attempted to replicate the observation that African Americans are more prone to receive excessive doses of antipsychotics, even after variables that have not been well explored in previous studies (smoking and antipsychotic potency) are controlled for.
METHOD: The populations of 2 neighboring U.S. state hospitals, which were screened for patients who smoked, were included. The total sample comprised 316 patients from the first hospital (surveyed in 1990) and 447 patients from the second hospital (surveyed in 1992) who were taking antipsychotics and were either African American or white. An excessive antipsychotic dose (greater than 1000 mg of chlorpromazine equivalents per day) was the dependent variable in logistic regressions in all patients and in those patients with or without (DSM-III-R) schizophrenia.
RESULTS: In the total sample from both hospitals, excessive dosing was associated with schizophrenia, age under 56 years, long hospitalization duration, high-potency antipsychotics, second hospital, and depot antipsychotics. The odds of being prescribed excessive doses of typical antipsychotics were 1.8 times higher for African American than for white schizophrenic patients. African American race in schizophrenic patients appeared to be associated with the prescription of high-potency antipsychotics and with excessive dosing of this type of antipsychotic. Excessive dosing did not appear to be associated with race in nonschizophrenic patients nor in schizophrenic patients taking low-potency antipsychotics.
CONCLUSION: Pharmacogenetic differences are not likely to explain this racial difference in prescription of excessive dosing of high-potency antipsychotics, which suggests that clinician attitudes may be a possible explanation. In future studies, pharmacogenetic tests and control for confounding factors, such as smoking, will help to establish whether racial differences in dosing are influenced by different metabolic capacities or physician biases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444813     DOI: 10.4088/jcp.v63n1107

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  The heresy of African-centered psychology.

Authors:  Naa Oyo A Kwate
Journal:  J Med Humanit       Date:  2005

2.  Does race affect prescribing for acute psychosis? Evaluation by a case vignette.

Authors:  Anne Connolly; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

Review 3.  Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Authors:  Thomas R E Barnes; Carol Paton
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

4.  Correlates of high-dose antipsychotic prescription amongst outpatients with Schizophrenia in a Nigerian Hospital.

Authors:  Ihechiluru G Anozie; Bawo O James; Joyce O Omoaregba; Sunday O Oriji; Paul O Erohubie; Anthony C Enebe
Journal:  S Afr J Psychiatr       Date:  2022-04-29       Impact factor: 1.242

5.  High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies.

Authors:  Kang Sim; Hsin Chuan Su; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Gabor Ungvari; Tianmei Si; Yan Ling He; Eun Kee Chung; Yiong Huak Chan; Naotaka Shinfuku; Ee Heok Kua; Chay Hoon Tan; Norman Sartorius
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

6.  The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision.

Authors:  Darron T Smith; Sonya C Faber; NiCole T Buchanan; Dale Foster; Lilith Green
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

7.  Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: Is there a racial difference?

Authors:  Muideen O Bakare
Journal:  BMC Res Notes       Date:  2008-06-12

8.  Ethnicity and cardiovascular health inequalities in people with severe mental illnesses: protocol for the E-CHASM study.

Authors:  J Das-Munshi; M Ashworth; F Gaughran; S Hull; C Morgan; J Nazroo; A Roberts; D Rose; P Schofield; R Stewart; G Thornicroft; M J Prince
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-02-04       Impact factor: 4.328

9.  A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting.

Authors:  Thomas Maestri; David Anderson; Jose Calderon-Abbo; Taylor Waguespack; Margarita Echeverri
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.